A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

Clinical trial NCT03992131 · TERMINATED

Trial details

NCT number: NCT03992131
Sponsor: pharmaand GmbH
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Triple-negative Breast Cancer Urothelial Carcinoma Solid Tumor

Start date: 2019-06-28
Primary completion: 2022-03-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.